S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Adar1 Capital Management/Q2 2024

Adar1 Capital Management

Period: Q2 2024 Β· Filed: 2024-08-13
View on SEC EDGAR β†—
AUM
$530M
Total portfolio value
Positions
266
Reported securities
Top Holding
PTGX
10.5% $55.6M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2024-08-13) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
PTGXPROTAGONIST THERAPEUTICS INC$55.6M10.49%$35.20$131.62+273.9%
10.5%
CYTKCYTOKINETICS INC$46.3M8.73%$54.70$86.49+58.1%
8.7%
ROIVROIVANT SCIENCES LTD$43.9M8.28%$10.83$35.13+224.4%
8.3%
BOXXEA SERIES TRUST$37.9M7.15%$107.54$117.22+9.0%
7.2%
BBIOBRIDGEBIO PHARMA INC$32.0M6.05%$25.20$77.19+206.3%
6.0%
RPRXROYALTY PHARMA PLC$31.1M5.88%$24.90$57.77+132.0%
5.9%
KROSKEROS THERAPEUTICS INC$25.1M4.74%$43.77$11.26-74.3%
4.7%
INSMPUTINSMED INC$13.4M2.54%$66.34$111.60+68.2%
2.5%
IMVTIMMUNOVANT INC$12.6M2.38%$27.51$38.79+41.0%
2.4%
ABUSARBUTUS BIOPHARMA CORP$10.2M1.92%$3.12$4.87+56.1%
1.9%
INSMCALLINSMED INC$10.1M1.90%$66.34$111.60+68.2%
1.9%
MRKMERCK & CO INC$9.4M1.77%$119.72$129.56+8.2%
1.8%
RZLTREZOLUTE INC$8.9M1.68%$4.31$4.91+13.9%
1.7%
SLDBSOLID BIOSCIENCES INC$8.1M1.52%$6.27$10.84+72.9%
1.5%
EWTXEDGEWISE THERAPEUTICS INC$7.9M1.48%$19.38$39.56+104.1%
1.5%
PCSCPERCEPTIVE CAP SOLUTIONS COR$7.5M1.42%$10.08$11.00+9.1%
1.4%
ASNDASCENDIS PHARMA A/S$7.0M1.32%$133.98$274.50+104.9%
1.3%
TECXTECTONIC THERAPEUTIC INC$5.9M1.11%$15.90$37.93+138.6%
1.1%
QUREUNIQURE NV$5.5M1.03%$4.45$41.81+839.5%
1.0%
ABSIABSCI CORPORATION$5.2M0.99%$3.01$11.62+286.1%
1.0%
VKTXVIKING THERAPEUTICS INC$4.8M0.91%$55.32$37.44-32.3%
0.9%
ALKSALKERMES PLC$4.7M0.89%$24.39$54.58+123.8%
0.9%
SPYPUTSPDR S&P 500 ETF TR$4.3M0.82%$532.73$744.78+39.8%
0.8%
HLXBHELIX ACQUISITION CORP II$4.1M0.78%β€”β€”
0.8%
ANABANAPTYSBIO INC$3.9M0.74%$16.41$63.42+286.5%
0.7%
CERECEREVEL THERAPEUTICS HLDNG I$3.8M0.72%β€”β€”
0.7%
CRNXCRINETICS PHARMACEUTICALS IN$3.4M0.63%$46.07$42.23-8.3%
0.6%
BILSPDR SER TR$3.0M0.56%$84.38$91.44+8.4%
0.6%
INSMINSMED INC$2.8M0.53%$66.34$111.60+68.2%
0.5%
QTTBQ32 BIO INC$2.8M0.53%$18.98$13.09-31.0%
0.5%

Quarter-on-Quarter Activity

Q2 2024 vs. Q1 2024

New Positions (8)

TickerIssuerNotionalSince Filing
RZLTREZOLUTE INC$8.9M+13.9%
PCSCPERCEPTIVE CAP SOLUTIONS COR$7.5M+9.1%
TECXTECTONIC THERAPEUTIC INC$5.9M+138.6%
CRNXCRINETICS PHARMACEUTICALS IN$3.4M-8.3%
KALAKALA BIO INC$2.2M
KNSAKINIKSA PHARMACEUTICALS INTL$2.1M
BEAMBEAM THERAPEUTICS INC$1.7M
SLNOSOLENO THERAPEUTICS INC$1.6M

Exited Positions (8)

TickerIssuerNotional
MACKMERRIMACK PHARMACEUTICALS IN$13.3M
AVROAVROBIO INC$5.1M
FUSNFUSION PHARMACEUTICALS INC$3.8M
REGNREGENERON PHARMACEUTICALS$2.2M
SDGRSCHRODINGER INC$1.7M
LLYELI LILLY & CO$1.4M
NGMNGM BIOPHARMACEUTICALS INC$1.3M
KNSAKINIKSA PHARMACEUTICALS LTD$1.2M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
BBIOPUTBRIDGEBIO PHARMA INC$32.0M+105280.8%+206.3%
CYTKCALLCYTOKINETICS INC$46.1M+34054.5%+58.1%
MRKMERCK & CO INC$9.3M+25150.0%+8.2%
ANABCALLANAPTYSBIO INC$3.9M+15479.9%+286.5%
SVRACALLSAVARA INC$2.6M+11750.0%
INSMINSMED INC$13.4M+11711.8%+68.2%
INSMINSMED INC$10.0M+8723.5%+68.2%
RLMDRELMADA THERAPEUTICS INC$0.1M+8319.5%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
CYTKCALLCYTOKINETICS INC$-22.4M-100.0%+58.1%
BBIOPUTBRIDGEBIO PHARMA INC$-17.0M-99.8%+206.3%
APLSCALLAPELLIS PHARMACEUTICALS INC$-1.5M-99.6%
BBIOPUTBRIDGEBIO PHARMA INC$-16.9M-99.3%+206.3%
ALNYALNYLAM PHARMACEUTICALS INC$-34.6M-99.2%
ALNYALNYLAM PHARMACEUTICALS INC$-26.5M-99.0%
TYRATYRA BIOSCIENCES INC$-0.5M-98.9%
GOSSCALLGOSSAMER BIO INC$-0.8M-97.3%
← Back to Hedge Funds